This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Watchko JF, Maisels MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 2003;88:F455–8.
Ruud Hansen TW. Phototherapy for neonatal jaundice-therapeutic effects on more than one level? Semin Perinatol. 2010;34:231–4.
Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012;32:677–84.
Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393–400.
Lipsitz PJ, Gartner LM, Bryla DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985;75:422–6.
Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl J Med. 2008;359:1885–96.
Arnold C, Pedroza C, Tyson JE. Phototherapy in ELBW newborns: does it work? Is it safe? The evidence from randomized clinical trials. Semin Perinatol. 2014;38:452–64.
Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol. 2004;28:326–33.
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043–6.
Speck WT, Rosenkranz HS. Intracellular deoxyribonucleic acid-modifying activity of phototherapy lights. Pediatr Res. 1976;10:553–5.
Auger N, Laverdière C, Ayoub A, Lo E, Luu TM. Neonatal phototherapy and future risk of childhood cancer. Int J Cancer. 2019;145:2061–9.
Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res. 2008;654:93–5.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol. 2016;36:132–6.
Tyson JE Cycled phototherapy: a safer effective method to control the serum bilirubin of extremely premature infants? ClinicalTrials.gov Identifier: NCT03927833. Updated March 27, 2023. Accessed March, 2023. https://clinicaltrials.gov/ct2/show/study/NCT03927833
Millen GC, Yap C. Adaptive trial designs: what are multiarm, multistage trials? Arch Dis Child Educ Pr Ed. 2020;105:376–8.
Acknowledgements
The Journal club is a collaboration between the American Academy of Pediatrics-Section of Neonatal-Perinatal Medicine and the International Society for Evidence-based neonatology (EBNEO.org).
Author information
Authors and Affiliations
Contributions
PS conducted the literature review and primarily drafted the manuscript. SM helped develop the concept of the manuscript and assisted in its drafting. Both authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharma, P., Mukthapuram, S. What is the minimum duration of cycled phototherapy that is still effective in treating hyperbilirubinemia?. J Perinatol 43, 1449–1451 (2023). https://doi.org/10.1038/s41372-023-01759-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-023-01759-5